Please use this identifier to cite or link to this item: http://repositorio.cedes.org/handle/123456789/4547
Título : Guidance for providers offering misoprostol - alone for abortion amidst COVID-19
Autor corporativo: CEDES. Centro de Estudios de Estado y Sociedad
Gynuity. Health Project
Palabras clave : COVID-19;MISOPROSTOL;ABORTO LEGAL;ABORTO TERAPEUTICO
Fecha de publicación : Jul-2020
Editorial : CEDES; Gynuity
Resumen : This resource offers evidence-based guidance on abortion with misoprostol alone while limiting clinic visits and required tests to ensure the continuity of care. It can help providers make evidence-based adjustments in clinical practice to enable safe access to high quality care while limiting unnecessary visits to medical facilities and possibly reducing costs to people seeking abortion and to the health system. The guidance was developed in accordance with the World Health Organization’s and the International Federation of Gynecology and Obstetrics’ calls to maintain essential reproductive health services during the COVID-19 emergency1,2 and presents options for simplifying care after the crisis has passed.
URI : http://repositorio.cedes.org/handle/123456789/4547
Derechos: Open access
Creative Commons Attribution 4.0 International License
Appears in Collections:Libros

Files in This Item:
File Description SizeFormat 
MA-Covid-English-print-DRAFT.pdfPrintable version in english2,51 MBAdobe PDFThumbnail
View/Open
MA-Covid-English-Mobile-7.7.2020.pdfEnglish mobile version1,84 MBAdobe PDFThumbnail
View/Open
Show full item record

Page view(s)

305
checked on Sep 23, 2020

Download(s)

33
checked on Sep 23, 2020

Google ScholarTM

Check


This item is licensed under a Creative Commons License Creative Commons